Atlas FDA

Inspire Patient Remote

FDA premarket approval P130008/S082 · decided 2022-04-01

Approval details

PMA number
P130008
Supplement
S082
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Inspire Patient Remote
Generic name
Stimulator, hypoglossal nerve, implanted, apnea
Applicant
Inspire Medical Systems
Date received
2022-03-02
Decision date
2022-04-01
Days to decision
30 days
Decision code
OK30
Product code
MNQ
Advisory committee
Anesthesiology
Expedited review
No
Location
Maple Grove, MN
Statement
Notification of implementing automated final functional testing for the Model 2580 Patient Remote.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.